论文信息 - A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma. - 字舞流文

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma.

J. Hsieh | N. Agarwal | M. Fishman | M. Michaelson | T. Kuzel | U. Vaishampayan | A. Molina | R. Jain | U. Bapat | R. Xie | T. Hutson | W. Ye